Zhang L - Search Results

1

Expression patterns and polymorphisms of PTCH in Chinese hepatocellular carcinoma patients.

Fu X, Wang Q, Chen X, Huang X, Cao L, Tan H, Li W, Zhang L, Bi J, Su Q, Chen L. Fu X, et al. Among authors: zhang l. Exp Mol Pathol. 2008 Jun;84(3):195-9. doi: 10.1016/j.yexmp.2008.04.002. Epub 2008 May 2. Exp Mol Pathol. 2008. PMID: 18538319

2

Clinical significance of miR-221 and its inverse correlation with p27Kip¹ in hepatocellular carcinoma.

Fu X, Wang Q, Chen J, Huang X, Chen X, Cao L, Tan H, Li W, Zhang L, Bi J, Su Q, Chen L. Fu X, et al. Among authors: zhang l. Mol Biol Rep. 2011 Jun;38(5):3029-35. doi: 10.1007/s11033-010-9969-5. Epub 2010 Feb 10. Mol Biol Rep. 2011. PMID: 20146005

3

Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells.

Cao LQ, Chen XL, Wang Q, Huang XH, Zhen MC, Zhang LJ, Li W, Bi J. Cao LQ, et al. Acta Pharmacol Sin. 2007 Jun;28(6):879-87. doi: 10.1111/j.1745-7254.2007.00571.x. Acta Pharmacol Sin. 2007. PMID: 17506947

4

Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated.

Huang XH, Wang Q, Chen JS, Fu XH, Chen XL, Chen LZ, Li W, Bi J, Zhang LJ, Fu Q, Zeng WT, Cao LQ, Tan HX, Su Q. Huang XH, et al. Hepatol Res. 2009 Aug;39(8):786-94. doi: 10.1111/j.1872-034X.2009.00502.x. Epub 2009 Mar 25. Hepatol Res. 2009. PMID: 19473441

5

MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell.

Tan HX, Wang Q, Chen LZ, Huang XH, Chen JS, Fu XH, Cao LQ, Chen XL, Li W, Zhang LJ. Tan HX, et al. Med Oncol. 2010 Sep;27(3):654-60. doi: 10.1007/s12032-009-9264-2. Epub 2009 Jul 2. Med Oncol. 2010. PMID: 19572217

6

FAK is involved in invasion and metastasis of hepatocellular carcinoma.

Chen JS, Huang XH, Wang Q, Chen XL, Fu XH, Tan HX, Zhang LJ, Li W, Bi J. Chen JS, et al. Clin Exp Metastasis. 2010 Feb;27(2):71-82. doi: 10.1007/s10585-010-9306-3. Epub 2010 Feb 24. Clin Exp Metastasis. 2010. PMID: 20180147

7

miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.

Huang XH, Chen JS, Wang Q, Chen XL, Wen L, Chen LZ, Bi J, Zhang LJ, Su Q, Zeng WT. Huang XH, et al. Among authors: zhang lj. J Pathol. 2011 Nov;225(3):463-72. doi: 10.1002/path.2877. Epub 2011 Jun 13. J Pathol. 2011. PMID: 21671467

8

Clinical significance of decreased nidogen-2 expression in the tumor tissue and serum of patients with hepatocellular carcinoma.

Cheng ZX, Huang XH, Wang Q, Chen JS, Zhang LJ, Chen XL. Cheng ZX, et al. J Surg Oncol. 2012 Jan;105(1):71-80. doi: 10.1002/jso.22047. Epub 2011 Aug 3. J Surg Oncol. 2012. PMID: 21815147

9

miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.

Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q. Wang R, et al. Among authors: zhang l. Biomed Pharmacother. 2018 Jul;103:1632-1642. doi: 10.1016/j.biopha.2018.03.005. Epub 2018 May 7. Biomed Pharmacother. 2018. PMID: 29864952

10

Nudix hydrolase 1 is a prognostic biomarker in hepatocellular carcinoma.

Ou Q, Ma N, Yu Z, Wang R, Hou Y, Wang Z, Chen F, Li W, Bi J, Ma J, Zhang L, Su Q, Huang X. Ou Q, et al. Among authors: zhang l. Aging (Albany NY). 2020 Apr 27;12(8):7363-7379. doi: 10.18632/aging.103083. Epub 2020 Apr 27. Aging (Albany NY). 2020. PMID: 32341205 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134,767 results

Search Page

Filters